Biosysen
Latest round
- Angel
Last raised
- Jul 2022
Total raised
- Undisclosed
Investors
- 5
About Biosysen
Established in 2019 and based in Beijing, China, Biosysen Ltd. operates as a synthetic biology company that focuses on architected genome design and application. Yu Chen and Kang Kang are the CEO and founder of the company. The business of the company includes platform technology transformation, self-developed pipeline incubation and strain authorization. The company's products include Wet-lab, Dry-lab, OMICs-lab and Ferm-Foundry. The company focuses on research and development of food, daily chemical and protein drugs. The company adopts architected genome technology. The company will plan to cooperates with biological manufacturing enterprises, bulk chemical suppliers, pharmaceutical enterprises.
Who invested in Biosysen
5 investors across 2 rounds
See all investors in Biosysen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biosysen
Who invested in Biosysen?
Biosysen has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biosysen raised?
Biosysen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biosysen last raise money?
Biosysen's most recent round on record is a Angel, in Jul 2022.
What does Biosysen do?
Established in 2019 and based in Beijing, China, Biosysen Ltd.
Where is Biosysen headquartered?
Biosysen is headquartered in Shenzhen, China.
Which VCs invest in companies like Biosysen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Biosysen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Biosysen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.